Merck (MRK) Dividends Paid - Common (2009 - 2026)

Merck (MRK) posted quarterly Dividends Paid - Common of $2.1 billion for Q1 2026, up 2.68% YoY from $2.1 billion in Q1 2025, and up 4.31% sequentially from $2.0 billion in Q4 2025.

Merck (MRK) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Merck has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $2.1 billion for Q1 2026.

  • In Q1 2026, Dividends Paid - Common rose 2.68% year-over-year to $2.1 billion; the TTM figure through Mar 2026 stood at $8.2 billion (up 3.66% YoY), while the FY2025 annual figure was $8.2 billion, up 4.29% from the prior year.
  • Dividends Paid - Common climbed to $2.1 billion in Q1 2026, from $2.0 billion in the prior quarter.
  • Over the last five years, Dividends Paid - Common for MRK reached as high as $2.1 billion in Q1 2026 and fell as low as $1.7 billion in Q1 2022.
  • The 5-year median for Dividends Paid - Common is $2.0 billion (2024), against an average of $1.9 billion.
  • Annual changes were most pronounced in 2022 — Dividends Paid - Common advanced 6.51% — and 2026, when it gained 2.68%.
  • A 5-year view of Dividends Paid - Common shows it stood at $1.8 billion in 2022, then grew by 5.83% to $1.9 billion in 2023, then increased by 5.35% to $2.0 billion in 2024, then rose by 3.43% to $2.0 billion in 2025, then increased by 4.31% to $2.1 billion in 2026.
  • According to Business Quant data, Dividends Paid - Common over the past three periods registered $2.1 billion, $2.0 billion, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 1.55 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 3.13 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 3.09 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -3.29 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 2.11 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 1.36 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 1.04 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 2.45 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.11 Bn
Mar 31, 2026 2.11 Bn
Dec 31, 2025 2.02 Bn
Dec 31, 2025 2.02 Bn
Sep 30, 2025 2.03 Bn
Sep 30, 2025 2.03 Bn
Jun 30, 2025 2.08 Bn
Jun 30, 2025 2.08 Bn
Mar 31, 2025 2.05 Bn
Mar 31, 2025 2.05 Bn
Dec 31, 2024 1.95 Bn
Dec 31, 2024 1.95 Bn
Sep 30, 2024 1.95 Bn
Sep 30, 2024 1.95 Bn
Jun 30, 2024 1.99 Bn
Jun 30, 2024 1.99 Bn
Mar 31, 2024 1.95 Bn
Mar 31, 2024 1.95 Bn
Dec 31, 2023 1.85 Bn
Dec 31, 2023 1.85 Bn